HilleVax, Inc.·4

Feb 12, 4:05 PM ET

Maltbie Shane 4

4 · HilleVax, Inc. · Filed Feb 12, 2025

Insider Transaction Report

Form 4
Period: 2025-02-04
Maltbie Shane
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-02-11$1.76/sh4,345$7,65979,887 total
  • Sale

    Common Stock

    2025-02-04$1.89/sh3,946$7,45884,232 total
Footnotes (2)
  • [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units ("RSUs"), which sale was mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  • [F2]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices between $1.7508 and $1.7745. The Reporting Person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4